• Publications
  • Influence
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
Human immunoglobulin prepared for intravenous administration (IGIV) has a number of important uses in the treatment of disease. Some of these are in diseases for which acceptable treatmentExpand
Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma &
A major diagnostic intervention in the consideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the application and interpretation of vaccination. Specifically,Expand
A randomized double-blind trial
A novel method of large-scale chromatography has been developed to improve recovery and purity of immunoglobulin G (IgG) from pooled plasma. The current study compares safety, toxicity and efficacyExpand
Update on the use of immunoglobulin in human disease: A review of evidence
&NA; Human immunoglobulin preparations for intravenous or subcutaneous administration are the cornerstone of treatment in patients with primary immunodeficiency diseases affecting the humoral immuneExpand
Safety of IGIV therapy and infusion-related adverse events
  • M. Ballow
  • Medicine
  • Immunologic research
  • 26 May 2007
Patients with primary immunodeficiency diseases have been treated with intravenous gammaglobulin (IGIV) for over 20 years. Gamma globulins were first introduced as a therapeutic modality in 1952 byExpand
Family emotional climate, depression, emotional triggering of asthma, and disease severity in pediatric asthma: examination of pathways of effect.
OBJECTIVES (a) To assess emotional triggering of pediatric asthma and ascertain its contribution to disease morbidity and functional status; (b) to test whether negative family emotional climateExpand
Primary immunodeficiency disorders: antibody deficiency.
  • M. Ballow
  • Biology, Medicine
  • The Journal of allergy and clinical immunology
  • 1 April 2002
As a group, antibody deficiencies represent the most common types of primary immune deficiencies in human subjects. Often symptoms do not appear until the latter part of the first year of life, asExpand
Chronic Mononucleosis Syndrome
We present data on 14 patients with chronic symptoms of disabling fatigue in association with serologic evidence of active Epstein-Barr virus (EBV) infection. Two thirds were women, and the averageExpand
Newborn Screening for SCID in New York State: Experience from the First Two Years
PurposeTo describe the process and assess outcomes for the first 2 years of newborn screening for severe combined immunodeficiency (SCID NBS) in New York State (NYS).MethodsThe NYS algorithm utilizesExpand
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
A second anticomplementary material in cobra venom is described and characterized by its large molecular size (0.8 to 1.0 × 10 6 molecular weight), its action on the early components of complement,Expand